1. Introduction {#sec1}
===============

A dramatic increase in the total number of patients with diabetes worldwide shows that diabetes mellitus (DM) and its complications are rapidly becoming a major global public health concern. Every individual with DM is considered to be at risk of developing diabetic retinopathy (DR). DR is a diabetic complication that affects the blood vessels and causes death of retinal cells, ultimately leading to blindness [@bib1], [@bib2]. Indeed, DR is the most important cause of blindness occurring in working-age adults, and it is also the common microvascular complication of DM [@bib3]. The retina consists of multiple layers of retinal cells. Loss of cells from the various retinal layers seems to be a prominent feature of DR. Previous researchers observed DM-induced cell death in all retinal layers, implying that several types of retinal cells may be affected by DM [@bib4], [@bib5], [@bib6], [@bib7]. Understanding the retinal changes occurring during DM and developing new drug candidates are important for designing effective therapies for DR treatment. The precise mechanism of DR is not completely understood. However, it is believed that various factors such as oxidative stress, inflammation, cell death, and genetic and metabolic alterations are involved in the development and progression of DM and DR.

*Panax ginseng* Mayer has been a popular herbal medicine in Eastern Asia for \> 2,000 years. Recent studies have demonstrated various effects of ginseng, including antioxidant, antithrombotic, antihyperlipidemic, angiogenic, and anticancer effects [@bib8], [@bib9], [@bib10], [@bib11], [@bib12]. Korean Red Ginseng (KRG), produced by repeated heating and drying of the root of ginseng, has strong potent pharmacological actions effective in the treatment of several human diseases. In DM, KRG not only improves glucose control but also enhances the renal, auditory, and immune functions [@bib13], [@bib14], [@bib15], [@bib16], [@bib17].

Microarrays are high-throughput genomic tools that offer the fastest and most comprehensive molecular evaluations [@bib18]. Over the past few years, microarrays have been used to compare the global changes in gene expression profiles to enable researchers investigate the molecular and functional alterations of genes in human diseases such as DM [@bib19], [@bib20], [@bib21], [@bib22].

In the current study, the systematic analysis of gene expression profiling was performed in the retinal tissues of rats with streptozotocin (STZ)-induced diabetes before and after KRG treatment to identify the mechanism for the mitigating effect of KRG on retinopathy.

2. Materials and methods {#sec2}
========================

2.1. Animals {#sec2.1}
------------

Seven-wk-old male Sprague--Dawley (SD) rats were housed under a 12 h:12 h light-dark cycle at room temperature. All the rats were allowed water *ad libitum*. The rats were divided into normal control, DM, and KRG-treated DM groups. The rats were injected intravenously with a single dose of STZ (50 mg/kg body weight; Sigma-Aldrich Corporation, St. Louis, MO, USA). STZ was dissolved in 0.01M of sodium citrate buffer (pH 4.5), kept on an ice bath, and used within 15 min of preparation. The control rats were injected with the vehicle only. Two days after STZ administration, only the rats with a blood glucose level of \> 300 mg/dL were considered to have diabetes and included in further experiments. KRG powder was obtained from the Korea Ginseng Corporation (Daejeon, Korea). The general composition of the KRG powder was as follows: moisture 36%, solid volume 64%, ash 2.5%, total fat 0.05%, total crude saponin 70 mg/g, and total ginsenosides 20 mg/g. The rats in the KRG-treated group received KRG mixed into powdered food at a final concentration of 200 mg/kg/d for 10 wk. The control and DM groups received powdered food alone. In all the groups, \> 95% of food was consumed, implying that the rats received the intended doses of KRG.

2.2. Sample preparation {#sec2.2}
-----------------------

Total RNA was extracted from rat retinal cells by using the miRNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer\'s instructions. The total RNA pellet was dissolved in diethylpyrocarbonate water, and its quality and quantity was analyzed using the Bioanalyzer 2100 System (Agilent Technologies, Palo Alto, CA, USA). Gene expression was analyzed using the GeneChip Rat Genome 230 2.0 Arrays (Affymetrix, Santa Clara, CA, USA), which comprises \> 31,000 probe sets representing approximately 28,700 characterized rat genes. For each gene, 11 pairs of oligonucleotide probes were synthesized *in situ* on the arrays.

2.3. Microarray {#sec2.3}
---------------

Biotinylated complementary RNAs were prepared from 500 ng total RNA, according to the standard Affymetrix protocol. Briefly, following fragmentation, 15 μg of artificial RNA (aRNA) was hybridized for 16 h at 45°C on the GeneChip Rat Genome Array (Affymetrix). The GeneChips were washed and stained in the Fluidics Station 450 (Affymetrix) and then scanned by using the GeneChip Scanner 3000 7G (Affymetrix). The data obtained were analyzed by using the Robust Multichip Analysis (RMA) algorithm with Affymetrix default analysis settings and global scaling as the normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100. The normalized and log-transformed intensity values were then analyzed using GeneSpring GX 12.6.1 (Agilent Technologies). Fold-change filters were set to retain only upregulated genes present in ≥ 200% of the controls and downregulated genes present in \< 50% of the controls. Hierarchical clustering data were grouped according to similarity in behavior across the experiments by using GeneSpring GX 12.6.1. Clustering algorithm was based on the euclidean distance and average linkage.

2.4. Complementary DNA synthesis {#sec2.4}
--------------------------------

The total amount of the extracted RNA was determined spectrophotometrically at 260/280 nm. The RNA quality was assessed as the absence of smear of 18S and 28S bands by using Bioanalyzer 2100. RNA samples were stored at −70°C until further use. Complementary DNAs (cDNAs) were synthesized from 1 μg of total RNA by using the High-Capacity RNA-to-cDNA Kit (Applied Biosystems), according to the manufacturer\'s protocol.

2.5. Real-time quantitative polymerase chain reaction {#sec2.5}
-----------------------------------------------------

High-throughput real-time quantitative polymerase chain reaction (RT-qPCR) was performed using the Applied Biosystems Prism 7900 Sequence Detection System (PE Applied Biosystems, [www.appliedbiosciences.com](http://www.appliedbiosciences.com){#intref0010a}) in triplicates by using white-colored 384-well plates (ABgene, Hamburg, Germany) for intensifying the fluorescent signals by a factor of three. This system operates using a thermal cycler and a fiberoptics-directed laser to each of the 384 wells. The fluorescence emission from each well was collected using a charge-coupled device-camera, and the quantitative data were analyzed by using the Sequence Detection System Software (SDS version 2.2, PE Applied Biosystems). PCR primer sequences used in this study are given in [Table 1](#tbl1){ref-type="table"}. The reaction mixtures contained 10 pmol/μL of each primer and 2X SYBR Green PCR Master Mix (PE Applied Biosystems), which contains the HotStarTaq DNA-Polymerase in an optimized buffer, the Deoxynucleotide (dNTP) mix (with Deoxyuridine triphosphate, dUTP additive), the SYBRs Green I fluorescent dye, and the ROX dye as a passive reference. To each well of the 384-well RT-qPCR plates, serial dilutions (1, $1/2$, $1/4$, $1/8$, and $1/16$) of cDNA were added, which were then used to generate relative standard curves for the genes. All the primers were amplified using the same conditions: thermal cycling at 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C for 30 s and 60°C for 30 s, and finally at 72°C for 3 s. In order to exclude the presence of unspecific products, a melting curve analysis of the products was performed routinely after amplification via high-resolution data collection with a temperature increase from 60°C to 95°C, and with a ramp rate of 0.21°C/s. Then, the RT-qPCR cycle numbers were converted to the corresponding gene amounts (ng) on the basis of the equation.

2.6. Statistical analysis {#sec2.6}
-------------------------

Statistical significance between each group was estimated by Student *t* test, and the results were expressed as mean ± standard deviation (GraphPad Prism version 4; GraphPad Software, San Diego, CA, USA).

3. Results and discussion {#sec3}
=========================

3.1. Establishment of diabetic rat model {#sec3.1}
----------------------------------------

During the experiment, rats with diabetes gradually lost their body mass and developed high blood glucose levels. Two days after DM onset, the average blood glucose level in the DM group was \> 450 mg/dL; this level persisted with the progress of DM within 450--600 mg/dL range.

Prior to the microarray study, the effect of KRG on the biochemical indicators in the rats with STZ-induced DM was determined. The rats with KRG-treated DM did not show any change in body weight, plasma glucose, and hemoglobin A1c (HbA1c) levels as compared with those in rats with STZ-induced DM, suggesting that KRG has little effect on DM ([Figs. 1](#fig1){ref-type="fig"}A--C). The results, however, suggest that oral administration of KRG can lower the average levels of triglyceride and cholesterol in rats with KRG-treated DM than in rats with STZ-induced DM, although the difference in the levels is not statistically significant ([Figs. 1](#fig1){ref-type="fig"}D, 1E).

Abnormalities of plasma lipid and lipoprotein concentrations are common in DM. Patients with DM showed reduced plasma high-density lipoprotein (HDL) cholesterol and increased plasma triglyceride and low-density lipoprotein (LDL) cholesterol levels [@bib23], which are strongly correlated with cardiovascular complications [@bib24], [@bib25]. Furthermore, it has been reported that abnormal serum lipid levels in patients with DM can be restored by administration of antidiabetic agents to the patients [@bib26], [@bib27]. These results suggest that KRG exerts hypolipidemic effects in rats with established STZ-induced DM.

3.2. Identification of global gene expression changes {#sec3.2}
-----------------------------------------------------

Findings from a previous study have suggested the ameliorating effect of alcoholic ginseng extract on diabetic complications, which demonstrated biochemical and functional changes in mouse retina and heart [@bib28]. Accordingly, we explored global changes in gene expression to attempt systemic analysis of the effect of KRG on diabetic retinopathy.

Total RNAs extracted from rat retinal cells were analyzed using the whole rat genome microarray. To obtain a rough estimate of the number of patterns between DM and KRG+DM groups, we performed hierarchical clustering. In [Fig. 2](#fig2){ref-type="fig"}, red color indicates overexpression and green color indicates underexpression of genes. A total of 326 genes were differentially expressed in the DM rat retinal cells than in the control cells, of which 268 genes showed upregulated expression and 58 genes showed more than twofold downregulated expression. In the retina of KRG-treated DM rats, the expressions of 39 genes were upregulated and of 84 genes were downregulated as compared with those in the retina of rats with DM ([Table 2](#tbl2){ref-type="table"}). Thus, we observed a reversal of the pattern of the number of differentially expressed genes in the DM rat retinal cells by KRG treatment.

3.3. Functional classification of genes {#sec3.3}
---------------------------------------

The differentially expressed genes were divided into the following 19 functional groups: apoptosis, behavior, cell adhesion, cell communication, cell cycle, cell development, cell differentiation, cell migration, cell proliferation, growth, homeostasis, inflammatory response, immune response, lipid metabolism, response to stress, signal transduction, transcription, translation, and transport. The number of genes of DM and DM+KRG rat retina in each category is shown in [Fig. 3](#fig3){ref-type="fig"}A and 3B, respectively. As [Fig. 3](#fig3){ref-type="fig"}B displays, the number of genes altered in [Fig. 3](#fig3){ref-type="fig"}A showed a reversed pattern after KRG treatment, which indicates that the change in the expression of genes induced by DM may be restored by KRG treatment. These data revealed that KRG may play roles in different biological pathways in DR and that some of the genes involved in these pathways are fairly responsive to KRG treatment.

3.4. Effect of KRG in restoration of gene expression altered in DM {#sec3.4}
------------------------------------------------------------------

Ginseng is currently one of the most famous herbal medicines in the world, which is well known to be beneficial in the treatment of various diseases such as cancer, cardiovascular diseases, and DM. KRG, prepared by the traditional method of steaming and sun drying ginseng, has better pharmacological activities such as antioxidant, anti-inflammatory, anticarcinogenic, and ameliorative effects on blood circulation as compared to white ginseng prepared by only sun drying fresh ginseng [@bib29]. On using high pressure and temperature during KRG preparation, the total phenolic and flavonoid content increases and some ginsenosides (the major active ingredients of KRG) are newly produced [@bib30], [@bib31]. These components of ginseng have been reported to modulate the gene expression [@bib32], [@bib33].

In our experiment, numerous genes differentially expressed in DM rat retinal cells showed significant reversals by KRG treatment ([Table 3](#tbl3){ref-type="table"}). Altered genes in DM raise the possibility that these changes contribute to the pathogenesis of retinopathy. Indeed, the results involved several genes related to the development and progression of retinopathy, such as *Cd47* (or integrin-associated protein; IAP), *Cyp26a1*, *Igf1r*, *Litaf*, and *Mmp14.* Moreover, the markers of retinopathy, such as *Gfap*, *Crystallin*, and *Hmox1*, were also identified. *Hmox1* is known as an antioxidant gene mediating an adaptive response under pathophysiologic conditions, such as vascular disease [@bib34]. Although blood glucose level was unaffected by KRG administration in this experiment, a number of genes showed changes in their expression, which suggests more mechanisms, such as a direct modulation by components in KRG on gene expression.

We employed the Database for Annotation, Visualization, and Integrated Discovery (DAVID; <http://david.abcc.ncifcrf.gov/>) tools to analyze the gene ontology (GO) of selected genes, which allows enrichment of functional genes. We observed a range of degrees of GO term enrichments in a selected gene set ([Table 4](#tbl4){ref-type="table"}). Among the identified categories, most genes belonged to the intracellular signaling group. Several other selected genes were also related to cell death and apoptosis. These results indicate that the reversed expression of genes mediate alleviating effect of KRG by influencing various cell signals and retinal cell death during DM.

Taken together, our results demonstrate that the expression levels of numerous genes are significantly altered by KRG treatment in retinal cells of rats with DM; thus, they can be considered to be directly or indirectly associated with the alleviating activity of KRG toward diabetic complications.

3.5. Validation of microarray data {#sec3.5}
----------------------------------

To confirm the reliability of the microarray data, the expression of three differentially expressed genes, *Gfap*, *Igf1r*, and *Crygb*, related to retinopathy was analyzed by performing RT-qPCR. The expression levels of these three genes from retinal cells of rats with DM were upregulated as compared to those from control rat retinal cells, whereas they were decreased in the retinal cells of rats with KRG-treated DM ([Fig. 4](#fig4){ref-type="fig"}).

Glial fibrillary acidic protein (GFAP) is a representative marker associated with polyol pathway in diabetic retinopathy [@bib7]. In diabetic retina, GFAP is upregulated, indicating dysfunction and structural abnormalities of Müller cells [@bib35]. Insulin-like growth factor 1 receptor (IGF1R) is also increased in retinas of rats with DM in a time-dependent manner; moreover, Kummer et al [@bib36] and Kuang et al [@bib37] reported that reduced IGF1R immunoreactivity by using IGF-1 analogue can prevent predegenerative changes associated with the progression of DR, despite existence of sustained hyperglycemia. In our study, several subunits of crystallin showed greatly altered expression between DM and DM+KRG rat groups ([Table 3](#tbl3){ref-type="table"}). Crystallin acts as a small heat shock protein in the retina in response to stress, rather than as a structural protein [@bib38]. It is reported that crystallins at both the protein and messenger RNA (mRNA) levels were highly upregulated in SD rats with STZ-induced diabetes [@bib39], [@bib40], which is a hallmark of DM in the retina [@bib41].

The consistency of RT-qPCR results with the microarray data confirmed the influence of KRG on the expression of the selected genes. Furthermore, the data were consistent with the suggestion that KRG may contribute to the mitigation of retinopathy by altering the mRNA levels of retinopathy-related genes. Reversal of gene expression after KRG treatment may provide a validation of drug efficacy. From this perspective, reversal of transcriptional changes in KRG-treated rat retina implies that KRG can have therapeutic effects on DR by modulating the expression levels of relevant genes.
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![Changes in body weight and the serum biochemical parameters in different groups of rats.](gr1){#fig1}

![Hierarchical cluster image showing the differential gene expression profiles in DM and DM+KRG group. Gene expression levels of normal control rats are shown in black for base-lines; upregulated genes are shown in red color, whereas downregulated genes are shown in green color. DM, diabetes mellitus; KRG, Korean Red Ginseng.](gr2){#fig2}

![Functional classification of differentially expressed genes. Differentially expressed genes in (A) DM group compared with the control group or (B) DM+KRG group compared with DM group were classified into 19 groups and the numbers of genes in each group were shown as the graph. Red and blue bars indicate the number of upregulated (≥ 2.0) and downregulated (≤ 0.5) genes, respectively. DM, diabetes mellitus; KRG, Korean Red Ginseng.](gr3){#fig3}

![Analysis of the relative expression of differentially expressed genes by real-time quantitative polymerase chain reaction (PCR). Retina tissues were analyzed for *Gfap*, *Igf1r*, and *Crygb* messenger RNA levels by real-time quantitative PCR, as described in the Materials and methods section. Data are expressed as mean ± standard deviation of three independent experiments. \**p* \> 0.005.](gr4){#fig4}

###### 

Primer for real-time polymerase chain reaction

  Gene symbol              Primer sequence           Size
  ------------------------ ------------------------- ------
  *Crygb*                  F AATGTAATGGAGGGCTGCTG    124
  R AGCCAACTTTGGCGTTTG                               
  *Gfap*                   F TTGGCTCTGAATCCTTGGAA    135
  R GGGACTGAGCAACCAGGATA                             
  *Igf1r*                  F CCCTACCCAAACCCTTAACTG   179
  R CACTGGGAAGCGGAGAAA                               
  *Gapdh*                  F ATGATTCTACCCACGGCAAG    89
  R CTGGAAGATGGTGATGGGTT                             

###### 

The number of differentially expressed genes in retina of rats with diabetes before and after treatments of Korean Red Ginseng

                        Control vs. DM   DM vs. DM+KRG
  --------------------- ---------------- ---------------
  Upregulated genes     268              39
  Downregulated genes   58               84

DM, diabetes mellitus; KRG, Korean Red Ginseng.

###### 

List of genes showing reversed expression by Korean Red Ginseng in retina of rats with diabetes

  Description   Gene symbol                                                                                    Fold change(DM/Con)   Fold change(DM+KRG/DM)
  ------------- ---------------------------------------------------------------------------------------------- --------------------- ------------------------
  Adamts4       ADAM metallopeptidase with thrombospondin type 1 motif, 4                                      5.704                 0.336
  Adfp          Adipose differentiation related protein                                                        3.888                 0.284
  Aldh3a1       Aldehyde dehydrogenase 3 family, member A1                                                     10.476                0.421
  Alox5ap       Arachidonate 5-lipoxygenase activating protein                                                 2.694                 0.334
  Bcl3          B-cell CLL/lymphoma 3                                                                          3.228                 0.412
  Bfsp1         Beaded filament structural protein 1                                                           47.469                0.481
  Birc7         Baculoviral IAP repeat-containing 7                                                            4.274                 0.312
  C1qb          Complement component 1, q subcomponent, B chain                                                2.234                 0.486
  C1qc          Complement component 1, q subcomponent, C chain                                                3.839                 0.455
  Ccnd2         Cyclin D2                                                                                      2.713                 0.388
  Cd47          Cd47 molecule                                                                                  2.248                 0.495
  Cidea         Cell death-inducing DFFA-like effector a                                                       10.025                0.483
  Copg2         Coatomer protein complex, subunit gamma 2                                                      3.392                 0.322
  Crip          Cysteine-rich intestinal protein                                                               2.590                 0.499
  Cryga         Crystallin, gamma A                                                                            4.765                 0.368
  Crygb         Crystallin, gamma B                                                                            62.504                0.397
  Crygc         Crystallin, gamma C                                                                            78.570                0.483
  Crygd         Crystallin, gamma D                                                                            83.967                0.415
  Cryge         Crystallin, gamma E                                                                            5.100                 0.301
  Cyp26a1       Cytochrome P450, family 26, subfamily a, polypeptide 1                                         2.749                 0.483
  Dclk1         Doublecortin-like kinase 1                                                                     4.700                 0.330
  Dennd4a       DENN/MADD domain containing 4A                                                                 2.161                 0.445
  Edn2          Endothelin 2                                                                                   10.581                0.208
  Emp1          Epithelial membrane protein 1                                                                  4.698                 0.357
  Fancb         Fanconi anemia, complementation group B                                                        4.804                 0.386
  Fcgr2a        Fc fragment of IgG, low affinity IIa, receptor                                                 2.190                 0.468
  Fgl2          Fibrinogen-like 2                                                                              4.665                 0.492
  Gadd45g       Growth arrest and DNA-damage-inducible, gamma                                                  3.838                 0.345
  Gal           Galanin prepropeptide                                                                          3.789                 0.205
  Gfap          Glial fibrillary acidic protein                                                                12.043                0.482
  Gnb3          Guanine nucleotide binding protein (G protein), beta polypeptide 3                             2.735                 0.382
  Gpnmb         Glycoprotein (transmembrane) nmb                                                               10.825                0.483
  Hmox1         Heme oxygenase (decycling) 1                                                                   4.906                 0.500
  Igf1r         Insulin-like growth factor 1 receptor                                                          2.000                 0.490
  Il4ra         Interleukin 4 receptor, alpha                                                                  2.750                 0.252
  Inmt          Indolethylamine N-methyltransferase                                                            2.487                 0.442
  Irak2         Interleukin-1 receptor-associated kinase 2                                                     2.669                 0.210
  Kif11         Kinesin family member 11                                                                       2.152                 0.339
  Klf10         Kruppel-like factor 10                                                                         2.202                 0.378
  Krt12         Keratin 12                                                                                     41.472                0.263
  Krt18         Keratin 18                                                                                     3.840                 0.343
  Krt6a         Similar to keratin complex 2, basic, gene 6a                                                   3.399                 0.351
  Lcn2          Lipocalin 2                                                                                    16.957                0.434
  Lgals3        Lectin, galactoside-binding, soluble, 3                                                        40.062                0.372
  Litaf         Lipopolysaccharide-induced TNF factor                                                          4.198                 0.441
  Lypd2         Ly6/Plaur domain containing 2                                                                  7.488                 0.297
  Matn2         Matrilin 2                                                                                     3.221                 0.468
  Mlf1          Myeloid leukemia factor 1                                                                      3.459                 0.124
  Mmp14         Matrix metallopeptidase 14 (membrane-inserted)                                                 2.255                 0.487
  Mt1a          Metallothionein 1a                                                                             10.301                0.493
  Mt2A          Metallothionein 2A                                                                             18.029                0.433
  Muc3a         Mucin 3A, cell surface associated                                                              2.430                 0.131
  Pdpn          Podoplanin                                                                                     3.687                 0.430
  Plekha8       Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8   2.313                 0.396
  Postn         Periostin, osteoblast specific factor                                                          2.090                 0.387
  Prtg          Protogenin homolog (*Gallus gallus*)                                                           5.292                 0.377
  S100a3        S100 calcium binding protein A3                                                                3.271                 0.269
  Samd4a        Sterile alpha motif domain containing 4A                                                       4.179                 0.487
  Sec16b        SEC16 homolog B (*Saccharomyces cerevisiae*)                                                   2.733                 0.457
  Serpina3n     Serine (or cysteine) peptidase inhibitor, clade A, member 3N                                   7.249                 0.368
  Slc25a30      Solute carrier family 25, member 30                                                            2.251                 0.348
  Slc26a8       Solute carrier family 26, member 8                                                             3.966                 0.273
  Stat3         Signal transducer and activator of transcription 3                                             3.115                 0.397
  Stc1          Stanniocalcin 1                                                                                2.472                 0.497
  Tagln2        Transgelin 2                                                                                   3.708                 0.461
  Tbata         Thymus, brain and testes associated                                                            2.623                 0.468
  Timp1         TIMP metallopeptidase inhibitor 1                                                              11.742                0.282
  Tmbim1        Transmembrane BAX inhibitor motif containing 1                                                 5.420                 0.388
  Tmod1         Tropomodulin 1                                                                                 3.865                 0.407
  Cdr2          Cerebellar degeneration-related 2                                                              0.325                 2.300
  Grk1          G protein-coupled receptor kinase 1                                                            0.409                 2.307
  Herc3         Hect domain and RLD 3                                                                          0.413                 2.341
  Id3           Inhibitor of DNA binding 3                                                                     0.574                 2.263
  Lamb3         Laminin, beta 3                                                                                0.200                 2.333
  LOC689064     Beta-globin                                                                                    0.264                 2.262
  Pax4          Paired box 4                                                                                   0.436                 4.471
  Pla2r1        Phospholipase A2 receptor 1                                                                    0.408                 2.520
  Prc1          Protein regulator of cytokinesis 1                                                             0.317                 3.163
  RT1-S3        RT1 class Ib, locus S3                                                                         0.449                 2.086
  Sntg2         Syntrophin, gamma 2                                                                            0.449                 2.489
  Tmem116       Transmembrane protein 116                                                                      0.439                 2.533
  Trove2        TROVE domain family, member 2                                                                  0.473                 2.066

###### 

Overrepresented gene ontology biological process annotations associated with differential expression of selected messenger RNAs using the DAVID tool

  Term                                                      Count   Fold   *p*
  --------------------------------------------------------- ------- ------ ---------
  GO0035556: intracellular signaling cascade                10      2.3    0.0091
  GO0042981: regulation of apoptosis                        9       2.9    0.0036
  GO0043067: regulation of programmed cell death            9       2.8    0.0039
  GO0001654: eye development                                8       12.3   \<0.001
  GO0007423: sensory organ development                      8       7      \<0.001
  GO0009888: tissue development                             8       2.8    0.0076
  GO0043065: positive regulation of apoptosis               6       3.9    0.004
  GO0043068: positive regulation of programmed cell death   6       3.9    0.0042
  GO0010942: positive regulation of cell death              6       3.9    0.0043
  GO0043627: response to estrogen stimulus                  5       7.3    \<0.001

Database for Annotation, Visualization and Integrated Discovery (DAVID) tools were used for gene ontology (GO) analysis. Results show the top 10 GO terms that are significantly overrepresented (fold change \> 2 and *p* \< 0.01, Fisher\'s exact test) in the selected messenger RNAs of retinas of rats with diabetes.
